`

TiumBio

Biotechnology Research

Specialities :
Rare diseases
Hemophilia
Immuno-oncology
Discovery
Development

+3

revenue-icon Revenue
1M - 10M
funding-icon Total Funding
$15.45M
size-icon Size
11 - 50

Frequently Asked Questions About TiumBio

What does Tiumbio do?+

TiumBio (KOSDAQ: 321550) is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapeutics for patients with rare and incurable diseases. Our mission is to enhance the hope and happiness of humanity through scientific advancements. TiumBio currently has three leading pipeline assets in clinical trials, with TU2218 being investigated in Phase 2 and TU2670 and TU7710 in Phase 1. TU2218 is an oral immuno-oncology therapy targeting TGF-beta and VEGFR2, while TU2670 is an orally active non-peptide GnRH antagonist. Additionally, TU7710 is a bypass-factor treatment specifically designed for hemophilia patients who have developed neutralizing antibodies. TiumBio is located...

What are Tiumbio's specialties? +

Rare diseases,hemophilia,immuno-oncology,discovery,development,small molecules,women's health,and endometiosis

What is Tiumbio's industry? +

Tiumbio operates in the Biotechnology research industry.

What is Tiumbio's revenue? +

Tiumbio's revenue is 1m - 10m

What is Tiumbio's company size? +

Tiumbio has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.